Study Reveals Importance Of Timing For Cellular Signals, Suggests Possible Tactic For Cancer Therapeutics
Magic tricks work because they take advantage of the brain’s sensory assumptions, tricking audiences into seeing phantoms or overlooking sleights of hand. Now a team of UC San Francisco researchers has discovered that even brainless single-celled yeast have sensory biases that can be hacked by a carefully engineered illusion, a finding that could be used to develop new approaches to fighting diseases such as cancer.
“The ability to perceive and respond to the environment is a basic attribute of all living organisms, from the greatest to the smallest,” said Wendell Lim, PhD, the study’s senior author. “And so is the susceptibility to misperception. It doesn’t matter if the illusion is based on molecular sensors within a single cell or neurons in the brain.”
In the new study, published online Nov. 19, 2015 in Science Express, Lim and his team discovered that yeast cells falsely perceive a specifically timed pattern of stress – caused by alternating between low and mildly increased sodium levels – as a massive, continuously increasing ramp of stress. In response, the microbes end up over-responding and killing themselves. The results, Lim says, suggest a whole new way of looking at the perceptual abilities of simple cells and could even be used to develop new approaches to fighting diseases using the power of illusion.
Timing of stress response is yeast cells’ ‘Achilles heel’
“This discovery was a bit of an accident actually,” said Lim, chair of the Department of Cellular and Molecular Pharmacology at UCSF, director of the UCSF Center for Systems and Synthetic Biology, and a Howard Hughes Medical Institute (HHMI) investigator. “We were interested in the general issue of how cells interpret information over time. Frequency is a key aspect of all our communications, whether it’s hearing language or transmitting radio signals, but do cells themselves use this kind of information? It’s something we don’t know much about.”
To explore this question, two postdoctoral fellows in Lim’s lab, Ping Wei, PhD, now at Peking University School of Life Sciences, and Amir Mitchell, PhD, set up a system that allowed them to expose yeast to a mild stressor – a small increase in salt in the yeast’s environment – and to oscillate between the increased salt level and the baseline level at different frequencies.
Normally, sensor molecules in a yeast cell detect changes in salt concentration and instruct the cell to respond by producing a protective chemical. After this transient response, the cell can resume growing happily as if conditions had not changed. The researchers found that the cells were perfectly capable of adapting when they flipped the salt stress on and off every minute or every 32 minutes. But to their surprise, when they tried an eight-minute oscillation of precisely the same salt level the cells quickly stopped growing and began to die off.
“That was just a jaw-dropping moment,” said Mitchell. “These cells should be able to handle this level of osmotic stress, but at one particular frequency they just go haywire. We’d never seen anything like this before.”
Could sensory illusions be used to fight cancer?
Mitchell, who was first author on the new study, went on to inspect the cellular mechanism underlying this unexpected, frequency-dependent toxicity. Using mathematical modeling and experiments in which he tweaked the molecular wiring of the mitogen activated protein kinase (MAPK) pathway that mediates the cells’ salt-sensing system, he revealed a sensory misperception: Because of the way the MAPK pathway is set up, the cells interpret an eight-minute oscillation as an ever-increasing staircase of salt concentration. This leads to excessive activation of the cells’ protective response, and ultimately to their death (see Movie).
The Latest on: Cancer Therapeutics
via Google News
The Latest on: Cancer Therapeutics
- Therapeutic potential of PLK1 inhibition in triple-negative breast cancer on April 17, 2019 at 11:02 am
Science and Technology of Japan and Project for Development of Innovative Research on Cancer Therapeutics. We obtained the written forms of informed consent from all the patients regarding the use of ... […]
- New study targets Achilles' heel of pancreatic cancer, with promising results on April 17, 2019 at 10:02 am
"We also think that the anti-LIF antibody therapy could be useful, in combination with other therapeutics, to treat pancreatic cancer. This is very translatable research, and it's nice to be ... […]
- Here's Why Marker Therapeutics Fell as Much as 11.5% Today on April 17, 2019 at 9:22 am
Shares of Marker Therapeutics (NASDAQ:MRKR) fell over 11% today after the company announced that it will delay the release of preliminary clinical data from an ongoing phase 1 study for its MultiTAA T ... […]
- Turning Point Prices IPO, Raising $166M to Test Cancer Drugs on April 17, 2019 at 8:27 am
Turning Point Therapeutics raised more than $166 million ... which is developing targeted cancer drugs for patients that have developed resistance to other treatments, to sell 9.25 million shares ... […]
- Global Cervical Cancer Diagnostics & Therapeutics Market Forecasts to 2024 - ResearchAndMarkets.com on April 17, 2019 at 7:55 am
DUBLIN--(BUSINESS WIRE)--Apr 17, 2019--The "Cervical Cancer Diagnostics and Therapeutics Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering ... […]
- Boehringer Ingelheim, PureTech to Partner on Cancer Immunotherapies on April 17, 2019 at 7:30 am
Promise Beyond Cancer The targeting approach developed by Porter’s lab can potentially be applied to therapeutic molecules across a range of physiochemical properties and holds promise for the ... […]
- Global Blood Cancer Therapeutics Market Will Grow at a CAGR of Over 8% During 2019-2023 | Technavio on April 17, 2019 at 7:06 am
LONDON--(BUSINESS WIRE)--Technavio has announced the release of their research report on the Global Blood Cancer Therapeutics Market for the forecast period 2019-2023. This blood cancer therapeutics ... […]
- Biotech Brief: Optimism Rising for Cancer Treatment Advancements in 2019 on April 17, 2019 at 5:30 am
Overall, in 2018, the U.S. Food and Drug Administration (FDA) approved 18 new cancer therapeutics and expanded the use of 10 previously approved treatments to include new types of cancer. Active ... […]
- iTeos Therapeutics Initiates Phase 1/1b Trial with Differentiated Adenosine A2A Antagonist in Patients with Advanced Cancer on April 17, 2019 at 4:00 am
Gosselies, Belgium and Cambridge, MA – April 17, 2019 – iTeos Therapeutics SA, a privately-held biotechnology company developing novel cancer immunotherapies, announced today the first cohort of ... […]
- Cancer Pain Therapeutics Market is Booming| BioDelivery Science, ProStrakan Group, Teva pharmaceuticals on April 16, 2019 at 2:01 pm
A latest survey on Southeast Asia Cancer Pain Therapeutics Market is conducted covering various organizations of the industry from different geographies to come up with 100+ page report. The study is ... […]
via Bing News